NITRIC OXIDE AND RHEUMATOID ARTHRITIS
NITRIC OXIDE AND RHEUMATOID ARTHRITIS
批准号:
6100451
负责人:
Joe Brice Weinberg
金额:
$21.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-01 至 1999-08-31
关键词:
antiinflammatory agents articular cartilage clinical research enzyme activity enzyme induction /repression enzyme inhibitors human subject inflammation interferon alpha leukocyte activation /transformation mechanical stress monocyte nitric oxide nitric oxide synthase phagocytes rheumatoid arthritis tetracyclines tissue /cell culture
中文摘要
类风湿关节炎是一种引起重要的常见疾病
英文摘要
Rheumatoid arthritis is a common disease that causes important
suffering, disability, and increased mortality. There is a great need
for new insight into disease mechanisms. Nitric oxide (NO) plays a role
in inflammatory disorders, including RA. The factor(s) that induces
mononuclear cells in humans to express the inducible NO synthase (NOS2)
and to produce NO has not fully been clearly identified. Our recent
studies have indicated that interferon-alpha (IFN-alpha) potently
"activates" monocytes to express NOS2 and produce NO. We hypothesize
that IFN-alpha is overproduced systemically and locally (in joint
tissues) in RA and that this contributes to the. NOS2 activation and
inflammation seen in patients with RA. The anti-inflammatory actions of
tetracycline-related drugs are independent of their anti-microbial
actions. While these drugs inhibit matrix metalloproteinases, they also
inhibit expression of NOS2 in vitro. We hypothesize that the NOS2
inhibitory actions account in part for their anti-inflammatory effects
in vivo. Patients with RA, because of pain, splinting, and joint
deformities place abnormal mechanical stresses on their articular
cartilage. We showed that mechanical stress induces NO production by
that cartilage. We hypothesize that NO is overproduced in cartilage of
RA patients (as compared to that of normal subjects or subjects with
osteoarthritis) in response to mechanical stress, and that the induced
NO alters cartilage homeostasis in RA.
Our aims are to (1) determine the role of IFN-alpha in the "activation"
of human mononuclear phagocytes for NOS2 expression and NO production in
RA; (2) determine' whether treatment of RA patients with doxycycline
reduces their blood mononuclear cell NOS expression and NO production;
and (3) determine the role of mechanical stress on cartilage NOS
expression and NO production in RA.
Accomplishing our proposed work will answer important questions
regarding NO, NOS2, IFN-alpha, and mechanical stress, and their inter-
relationships in RA. These answers will provide important new
information that may lead to new approaches to the treatment of RA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nitric Oxide and Malaria
-
批准号:8331804
-
项目类别:
-
资助金额:$19.92万
-
财政年份:2012
-
负责人:Joe Brice Weinberg
-
依托单位:
Biologic Scaffold Prostheses to Enhance Meniscus Repair
-
批准号:8839270
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Joe Brice Weinberg
-
依托单位:
Biologic Scaffold Prostheses to Enhance Meniscus Repair
-
批准号:7888242
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Joe Brice Weinberg
-
依托单位:
Biologic scaffold prostheses to enhance meniscus repair
-
批准号:7749325
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Joe Brice Weinberg
-
依托单位:
Biologic Scaffold Prostheses to Enhance Meniscus Repair
-
批准号:8838088
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Joe Brice Weinberg
-
依托单位:
Inducible NOS as a Treatment Target in CLL
-
批准号:6633986
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2001
-
负责人:Joe Brice Weinberg
-
依托单位:
Inducible NOS as a Treatment Target in CLL
-
批准号:6514971
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2001
-
负责人:Joe Brice Weinberg
-
依托单位:
Inducible NOS as a Treatment Target in CLL
-
批准号:6757870
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2001
-
负责人:Joe Brice Weinberg
-
依托单位:
Inducible NOS as a Treatment Target in CLL
-
批准号:6886702
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2001
-
负责人:Joe Brice Weinberg
-
依托单位:
Inducible NOS as a Treatment Target in CLL
-
批准号:6320364
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2001
-
负责人:Joe Brice Weinberg
-
依托单位:
NITRIC OXIDE AND RHEUMATOID ARTHRITIS
-
批准号:6348928
-
项目类别:
-
资助金额:$21.36万
-
财政年份:2000
-
负责人:Joe Brice Weinberg
-
依托单位:
NITRIC OXIDE AND RHEUMATOID ARTHRITIS
-
批准号:6201511
-
项目类别:
-
资助金额:$21.36万
-
财政年份:1999
-
负责人:Joe Brice Weinberg
-
依托单位:
NITRIC OXIDE AND SEVERE MALARIA
-
批准号:2556315
-
项目类别:
-
资助金额:$48.12万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
NITRIC OXIDE AND SEVERE MALARIA
-
批准号:2887552
-
项目类别:
-
资助金额:$48.39万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
Arginine, Nitric Oxide, and Severe Malaria
-
批准号:8307935
-
项目类别:
-
资助金额:$56.94万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
Arginine, Nitric Oxide, and Severe Malaria
-
批准号:7932280
-
项目类别:
-
资助金额:$58.01万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
NITRIC OXIDE AND RHEUMATOID ARTHRITIS
-
批准号:6235730
-
项目类别:
-
资助金额:$20.99万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
Arginine, Nitric Oxide, and Severe Malaria
-
批准号:7528065
-
项目类别:
-
资助金额:$60.39万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
Nitric Oxide and Severe Malaria
-
批准号:6749010
-
项目类别:
-
资助金额:$51.42万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
Nitric Oxide and Severe Malaria
-
批准号:6619982
-
项目类别:
-
资助金额:$38.9万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
海外基金